Q32 Bio Inc expected to post a loss of 54 cents a share - Earnings Preview

Q32 Bio

31/07/2026 14:05

Q32 Bio Inc QTTB.OQ QTTB.O is expected to  show no change in quarterly revenue when it reports  results on August 4 (estimated) for the period ending June 30 2026

​LSEG's mean analyst estimate for Q32 Bio Inc is for a loss of 54 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Q32 Bio Inc is $38.00, about 144.2% above its last closing price of $15.56
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.68
-0.68
-0.54
Beat
20.6
Dec. 31 2026
-0.80
-0.86
3.65
Beat
524.1
Sep. 30 2025
-1.39
-1.19
-0.60
Beat
49.5​
Jun. 30 2025
-0.99
-0.98
-0.78
Beat
20.4
​​Mar. 31 2025
-1.20
-1.23
-0.90
Beat
26.8
Dec. 31 2024
-1.50
-1.51
-1.16
Beat
23.2​
Sep. 30 2024
-1.40
-1.40
-1.46
Missed
-4
Jun. 30 2024
-1.05
-1.04
-1.42
Missed
-36.2
This summary was machine generated July 31 at 13:05 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)